期刊文献+

脂联素多聚体及基因多态性与2型糖尿病 被引量:3

Relationship of multimers and genetic polymorphism of adiponectin with type 2 diabetes
下载PDF
导出
摘要 脂联素是新近发现的脂肪细胞分泌的特异性细胞因子,在机体糖和脂肪代谢、维持能量平衡过程中发挥重要作用。正常人脂联素基因序列中存在相当数量的等位基因单核苷酸多态性(SNPs),其中5′侧翼区-11377(C/G)和外显子2+45(T/G)遗传多态性与脂联素血浆水平以及与肥胖、2型糖尿病(type 2 d iabetes m ellitus,T2DM)和冠状动脉粥样硬化有关。脂联素在血浆中以高分子量(h igh molecu lar we ight,HMW)的多聚体和低分子量(low molecu lar we ight,LMW)的六聚体2种形式存在。HMW脂联素增加与胰岛素敏感性呈正相关,LMW脂联素的功能需要进一步探讨研究。 Adiponectin is a novel specific cytokine found in adipocytes. It plays an important role in the metabolism of glucose and lipids as well as regulation of energy balance in the human body There are a lot of single nucleotide polymorphisms (SNPs) in the gene sequences of adiponectin. Some studies showed that the genetic polymorphism of adiponectin -11 377 (C/G) and +45 (T/G) located in the 5'-flanking region are associated with the development of obesity, type 2 diabetes, and atherosclerosis and plasma level of adiponectin. Adiponectin exists by two forms of high molecular weight of muhimers and low molecular weight of hexamer. The increase of high molecular weight of muhimers is positively correlated with insulin sensitivity; however, the function of low molecular weight of hexamer isn't clear.
出处 《国际病理科学与临床杂志》 CAS 2006年第5期432-435,共4页 Journal of International Pathology and Clinical Medicine
基金 国家自然科学基金(30572230) 教育部新世纪优秀人才支持计划基金(NCET-04-0749)
关键词 脂联素 单核苷酸多态性 多聚体 2型糖尿病 adiponectin single nucleotide oolvmorohism muhimers tvoe 2 diabetes
  • 相关文献

参考文献29

  • 1Hu E, Liang P, Spiegelman B M. AdipoQ is a novel adipose-specific gene dysregulated in obesity[J]. J Biol Chem, 1996, 271( 18 ) : 10697-10703.
  • 2Maeda K, Okubo K, Shimomura l, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 ( AdiPose Most abundant Gene transcript 1 ) [ J]. Biochem Biophys Res Commun, 1996, 221 (2) :286-289.
  • 3Combs T P, Wagner J A, Berger J, et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization[ J]. Endocrinology, 2002, 143 ( 3 ) :998-1007.
  • 4Yu J G, Javorschi S, Hevener A L, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects [ J ]. Diabetes, 2002, 51 (10) : 2968-2974.
  • 5Maeda N, Takahashi M, Funahashi T, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein[ J ]. Diabetes, 2001, 50(9 ) :2094-2099.
  • 6Olefsky J M. Treatment of insulin resistance with peroxisome proliferator-aetivated receptor gamma agonists[ J]. J Clin Invest, 2000,106(4) :467-472.
  • 7Scherer P E,Williams S, Fogliano M, et al. A novel serum protein similar to Clq produced exclusively in adipocytes[ J]. J Biol Chem,1995, 270 (45) :26746-26749.
  • 8Fruebis J,Tsao T S, Javorschi S, et al. Proteolytic cleavage product of 30 kD adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss [ J ]. Proc Natl Acad Sci USA, 2001, 98(4) :2005-2010.
  • 9Maeda N,Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 [ J ]. Nat Med,2002, 8(7) :731-737.
  • 10Yamauchi T, Kaman J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[ J]. Nat Med, 2002, 8( 11 ) :1288-1295.

二级参考文献17

  • 1Maeda K, Okubo AK, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, APM1 (Adipose Most Abundant Gene Transcrip 1). Biochem Biophys Res Commun, 1996,221:286-289.
  • 2Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in Japanese population.Diabetes, 2002,51:536-540.
  • 3Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med, 2002,8:731-737.
  • 4Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of metabolic syndrome. PNAS, 2000,97:14478-14483.
  • 5Yamauchi T, Kamon J, Waki H, et al. Replenishment of the fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001,7:941-946.
  • 6Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995, 270:26746-26749.
  • 7Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinmia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001, 86:1930-1935.
  • 8Haffner SM, Miettinen H, Stem MP. The homeostasis model in the San Antonio Heart Study. Diadetes Care, 1997,20:1087-1092.
  • 9Hara K, Boutin P, Mori Y, etal. Genetic variation in the gene encoding adipnectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes, 2002,51:536-540.
  • 10Filippi E, Sentinelli F, Trischitta V, et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum G enet,2004,12:199-205.

共引文献48

同被引文献11

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部